annual accounts payable:
$4.34B-$402.62M(-8.50%)Summary
- As of today (August 20, 2025), GSK annual accounts payable is $4.34 billion, with the most recent change of -$402.62 million (-8.50%) on December 31, 2024.
- During the last 3 years, GSK annual accounts payable has fallen by -$1.81 billion (-29.41%).
- GSK annual accounts payable is now -29.41% below its all-time high of $6.14 billion, reached on December 31, 2021.
Performance
GSK Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$20.31B+$755.02M(+3.86%)Summary
- As of today (August 20, 2025), GSK quarterly accounts payable is $20.31 billion, with the most recent change of +$755.02 million (+3.86%) on June 30, 2025.
- Over the past year, GSK quarterly accounts payable has increased by +$2.30 billion (+12.78%).
- GSK quarterly accounts payable is now -31.35% below its all-time high of $29.58 billion, reached on March 31, 2018.
Performance
GSK quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
GSK Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.5% | +12.8% |
| 3 y3 years | -29.4% | +12.9% |
| 5 y5 years | -21.0% | +6.4% |
GSK Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.4% | at low | at high | +15.1% |
| 5 y | 5-year | -29.4% | at low | -14.6% | +241.0% |
| alltime | all time | -29.4% | +4870.0% | -31.4% | >+9999.0% |
GSK Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $20.31B(+3.9%) |
| Mar 2025 | - | $19.55B(+1.8%) |
| Dec 2024 | $4.34B(-8.5%) | $19.21B(-0.4%) |
| Sep 2024 | - | $19.28B(+7.1%) |
| Jun 2024 | - | $18.01B(-2.5%) |
| Mar 2024 | - | $18.47B(-8.6%) |
| Dec 2023 | $4.74B(+1.9%) | $20.20B(+6.2%) |
| Sep 2023 | - | $19.02B(+7.2%) |
| Jun 2023 | - | $17.74B(+0.5%) |
| Mar 2023 | - | $17.64B(-9.8%) |
| Dec 2022 | $4.65B(-24.3%) | $19.56B(+8.7%) |
| Sep 2022 | - | $17.99B(+0.0%) |
| Jun 2022 | - | $17.98B(-16.0%) |
| Mar 2022 | - | $21.41B(-9.9%) |
| Dec 2021 | $6.14B(+3.1%) | $23.78B(+15.8%) |
| Sep 2021 | - | $20.54B(+4.2%) |
| Jun 2021 | - | $19.71B(-2.2%) |
| Mar 2021 | - | $20.16B(+238.5%) |
| Dec 2020 | $5.96B(+8.5%) | $5.96B(-69.6%) |
| Sep 2020 | - | $19.58B(+2.5%) |
| Jun 2020 | - | $19.09B(+0.6%) |
| Mar 2020 | - | $18.98B(-4.1%) |
| Dec 2019 | $5.49B(+18.3%) | $19.79B(+9.0%) |
| Sep 2019 | - | $18.16B(+6.6%) |
| Jun 2019 | - | $17.04B(-2.6%) |
| Mar 2019 | - | $17.49B(-2.2%) |
| Dec 2018 | $4.64B(-2.7%) | $17.88B(+4.7%) |
| Sep 2018 | - | $17.07B(+3.1%) |
| Jun 2018 | - | $16.56B(-44.0%) |
| Mar 2018 | - | $29.58B(+4.3%) |
| Dec 2017 | $4.77B(+7.4%) | $28.37B(+6.6%) |
| Sep 2017 | - | $26.62B(+4.7%) |
| Jun 2017 | - | $25.43B(+69.0%) |
| Mar 2017 | - | $15.05B(+238.6%) |
| Dec 2016 | $4.44B(-3.4%) | $4.44B(-70.8%) |
| Sep 2016 | - | $15.22B(+4.6%) |
| Jun 2016 | - | $14.54B(-2.3%) |
| Mar 2016 | - | $14.89B(+223.9%) |
| Dec 2015 | $4.60B(+5.7%) | $4.60B(-64.3%) |
| Sep 2015 | - | $12.90B(+0.6%) |
| Jun 2015 | - | $12.83B(+0.6%) |
| Mar 2015 | - | $12.75B(+193.2%) |
| Dec 2014 | $4.35B(-4.1%) | $4.35B(-64.4%) |
| Sep 2014 | - | $12.23B(+2.9%) |
| Jun 2014 | - | $11.88B(-2.4%) |
| Mar 2014 | - | $12.17B(+168.3%) |
| Dec 2013 | $4.54B | $4.54B(-64.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $12.62B(+6.2%) |
| Jun 2013 | - | $11.88B(+1.5%) |
| Mar 2013 | - | $11.71B(+170.3%) |
| Dec 2012 | $4.33B(+8.6%) | $4.33B(-65.1%) |
| Sep 2012 | - | $12.41B(+10.5%) |
| Jun 2012 | - | $11.23B(-0.4%) |
| Mar 2012 | - | $11.28B(+182.6%) |
| Dec 2011 | $3.99B(+19.1%) | $3.99B(-64.3%) |
| Sep 2011 | - | $11.18B(-4.2%) |
| Jun 2011 | - | $11.67B(+0.5%) |
| Mar 2011 | - | $11.61B(+246.5%) |
| Dec 2010 | $3.35B(+11.9%) | $3.35B(-68.7%) |
| Sep 2010 | - | $10.72B(+9.1%) |
| Jun 2010 | - | $9.83B(+228.0%) |
| Dec 2009 | $3.00B(+80.7%) | $3.00B(+80.7%) |
| Dec 2008 | $1.66B(-10.6%) | $1.66B(-10.6%) |
| Dec 2007 | $1.85B(+9.5%) | $1.85B(+9.5%) |
| Dec 2006 | $1.69B(+20.4%) | $1.69B(+20.4%) |
| Dec 2005 | $1.41B(+3.6%) | $1.41B(+3.6%) |
| Dec 2004 | $1.36B(+10.5%) | $1.36B(+10.5%) |
| Dec 2003 | $1.23B(+6.7%) | $1.23B(+6.7%) |
| Dec 2002 | $1.15B(+4.1%) | $1.15B(+4.1%) |
| Dec 2001 | $1.11B(-8.7%) | $1.11B(-89.5%) |
| Sep 2001 | - | $10.54B(+9.8%) |
| Jun 2001 | - | $9.60B(-7.3%) |
| Mar 2001 | - | $10.36B(+755.9%) |
| Dec 2000 | $1.21B(-6.3%) | $1.21B(-85.5%) |
| Sep 2000 | - | $8.35B(-1.2%) |
| Jun 2000 | - | $8.45B(-0.3%) |
| Mar 2000 | - | $8.48B(+1329.7%) |
| Dec 1999 | $1.29B(+165.1%) | $593.03M(+25.9%) |
| Jun 1999 | - | $470.92M(-2.8%) |
| Dec 1998 | $487.49M(-0.9%) | $484.59M(-74.8%) |
| Jun 1998 | - | $1.93B(+288.8%) |
| Dec 1997 | $491.97M(+6.5%) | $495.17M(+7.9%) |
| Dec 1996 | $462.05M(+1.6%) | $458.86M(-87.2%) |
| Dec 1995 | $454.91M(+56.8%) | - |
| Jun 1995 | - | $3.59B(+1138.5%) |
| Jun 1994 | $290.18M(+9.0%) | $289.61M(+7.8%) |
| Jun 1993 | $266.29M(-13.6%) | $268.55M(-12.8%) |
| Jun 1992 | $308.27M(-42.0%) | $307.80M(+30.0%) |
| Jun 1991 | $531.85M(+127.7%) | $236.84M(+1.4%) |
| Jun 1990 | $233.56M(+33.4%) | $233.56M(+33.4%) |
| Jun 1989 | $175.13M(+7.9%) | $175.13M(+7.9%) |
| Jun 1988 | $162.34M(+32.7%) | $162.34M(+32.7%) |
| Jun 1987 | $122.35M(+40.3%) | $122.35M(+40.3%) |
| Jun 1986 | $87.24M | $87.24M |
FAQ
- What is GSK plc annual accounts payable?
- What is the all time high annual accounts payable for GSK plc?
- What is GSK plc annual accounts payable year-on-year change?
- What is GSK plc quarterly accounts payable?
- What is the all time high quarterly accounts payable for GSK plc?
- What is GSK plc quarterly accounts payable year-on-year change?
What is GSK plc annual accounts payable?
The current annual accounts payable of GSK is $4.34B
What is the all time high annual accounts payable for GSK plc?
GSK plc all-time high annual accounts payable is $6.14B
What is GSK plc annual accounts payable year-on-year change?
Over the past year, GSK annual accounts payable has changed by -$402.62M (-8.50%)
What is GSK plc quarterly accounts payable?
The current quarterly accounts payable of GSK is $20.31B
What is the all time high quarterly accounts payable for GSK plc?
GSK plc all-time high quarterly accounts payable is $29.58B
What is GSK plc quarterly accounts payable year-on-year change?
Over the past year, GSK quarterly accounts payable has changed by +$2.30B (+12.78%)